Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52,265,866
-
Total 13F shares
-
31,923,615
-
Share change
-
-431,421
-
Total reported value
-
$83,959,164
-
Price per share
-
$2.63
-
Number of holders
-
70
-
Value change
-
-$1,543,118
-
Number of buys
-
24
-
Number of sells
-
34
Institutional Holders of ENZO BIOCHEM INC - Common Stock (ENZB) as of Q4 2019
As of 31 Dec 2019,
ENZO BIOCHEM INC - Common Stock (ENZB) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,923,615 shares.
The largest 10 holders included
HARBERT FUND ADVISORS, INC., Evermore Global Advisors, LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, ARIEL INVESTMENTS, LLC, STATE STREET CORP, and Fondren Management LP.
This page lists
70
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.